GMC and Mayo Meeting — 1st Multidisciplinary Mayo Clinic and Galilee Medical Center Joint Meeting – Where the, Kidney, Heart and Brain Meet
The Galilee Medical Centre *Nahariya, ISRAEL Visit the Venue to read more
We are pleased to announce The 1st Multidisciplinary Mayo Clinic and Galilee Medical Center Joint Meeting – Where the, Kidney, Heart and Brain Meet, which will be held on March 9, 2015, in Nahariya, Israel.
In the first collaboration of its kind in Israel, the world esteemed Mayo Clinic and the Medical Center of the Galilee are holding a conference. The meeting will focus on advancing the multidisciplinary approach to covering inter-organ crosstalk, where the kidney, heart and brain interact in a variety of fields.
The 1st Multidisciplinary Mayo Clinic and Galilee Medical Center Joint Meeting will take place in Nahariya, the northernmost coastal city of Israel. Situated on the beautiful Mediterranean Sea, Nahariya is the gateway to the picturesque Western Galilee. The area is extremely unique and is known for its cultural diversity, hospitality, excellent weather, and seaside promenade.
For further information on the region click here
For further information on Treasures of the Galilee click here
For further information about the Galilee Medical Center click here
For Information on the Faculty of Medicine Bar-Ilan click here
We look forward to welcoming you to The 1st Multidisciplinary Mayo Clinic and Galilee Medical Center Joint Meeting and to facilitate strengthening of scientiﬁc and personal ties amongst the participants.
We invite you to submit your abstracts for our poster session. Please note the deadline of December 15, 2014.
|Batya Kristal, MD, MHA, FASN, Israel|
|Lilach O. Lerman, MD, PhD, FAHA, FASN, FASH, USA|
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Deadline: The deadline for submitting an abstract is December 31, 2014 and authors will be notified of acceptance decisions by January 31, 2015.
Official Language: The official language of the conference is English. All abstracts must be submitted in English.
Size: One page, Size A4, up to 300 words in length, single space.
Font: Times New Roman, font size: 12
Margin: 2.5 cm on each side of the page
Title: Title must be written in uppercase Letters, centered at the top of the page.
Authors: Authors citation will include last name, ﬁrst and middle initials, afﬁliation details for each author, including: department; institution / hospital; city; country.
The name of the presenting author should be underlined.
Contact information should include email address and phone number.
All abstracts must be submitted online as an attached Word ﬁle to Rena Borenstein at the following e-mail address: firstname.lastname@example.org
This conference was made possible by the generous support of the Claire Friedlander Family Foundation, the professional Societies of Nephrology, Neurology and Cardiology, the Medical Center of the Galilee, the Bar-Ilan Faculty of Medicine, the Friends of the Galilee Medical Center and the following pharmaceutical and medical device companies.
We are committed to acknowledging our supporters for their generosity and dedication.
Medison is Israel’s leading marketing group, representing innovative niche healthcare solutions companies such as Biogen Idec., Amgen, Shire, Boston Scientific and Ipsen. Employing a comprehensive approach to sales and service, Medison supplies and maintains long-standing relations with HMOs (Health Maintenance Organizations), local medical centers and physicians. Backed by three generations of experience in the healthcare industry since 1937, Medison is uniquely qualified to provide the complete spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli, Romanian and Slovakian healthcare markets.
Medison has offices and is active in Israel and Romania.
AbbVie is a global, research-based biopharmaceutical company that combines advanced science with a deep knowledge of diseases, patient needs and healthcare systems around the world.
With a rich heritage, of more than 125 years*, AbbVie is committed to advance patient-centric solutions worldwide, and moving the Sustainable Healthcare debate forward, in order to extend healthy life years. To do so, AbbVie is already co-operating with academia, patient associations, physicians and care givers, governmental and non-governmental organizations and other research teams around the world. Innovation, open dialogue and extensive collaboration are key elements in addressing these important challenges.
* AbbVie provides health services to people in more than 170 countries and employ over 130 manufacturing, research and development, distribution and sales facilities, employing approximately 25,000 employees worldwide. AbbVie was formed in 2013 following separation from Abbott Laboratories.
Teva Medical is a part of Teva Israel. Teva Medical specializes in marketing of medical equipment and medical solutions for hospitals, HMO and private patients.
Teva medical line of marketing includes: medical equipment for hospitals, solutions, intensive care life supporting machinery, antiseptics, diagnostics advanced machines to laboratories, equipment for dialysis centers and solutions for Intravenous nutrition feed.
Sanofi is global healthcare leader focused on patients' needs with a diversified offer of medicines, vaccines and innovative therapeutic solutions, engaged in the research, development, manufacturing and marketing of healthcare products.110,000 Sanofi employees worldwide work daily with our partners to protect health, enhance life, provide hope and respond to the potential healthcare needs of 7 billion people around the world.Sanofi Israel is an affiliate of Sanofi and has been marketing its products locally for over 20 years. Sanofi Israel provides Israeli health care providers and their patients a broad spectrum of effective treatments for a wide variety of diseases.Sanofi Israel’s activities are performed via professional marketing and medical research teams. The company’s leading clinical research unit works in collaboration with large research groups in Israel and abroad. The company also has several strategic collaborations with local groups to promote its business development.Sanofi Israel has a strong legacy of products focusing on the following therapeutic areas: Diabetes , Thrombosis/Blood and Circulation, Oncology, Cardiovascular, Nephrology Urology, Central Nervous System, Consumer Health Care/OTC